Evaluation of Efficacy and Safety of QLC7401 Monotherapy in Participants With Non-familial Primary Hypercholesterolemia or Mixed Dyslipidemia: A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study
Latest Information Update: 05 Mar 2026
At a glance
- Drugs RBD-7022 (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Qilu Pharmaceutical
Most Recent Events
- 05 Mar 2026 New trial record